Now Available: Reference Standards for the new Ph. Eur. Cannabis/CBD Monographs
Recommendation

19/20 May 2026
All relevant GMP/GACP aspects for Medical Cannabis
The European Pharmacopoeia (Ph. Eur.) Suppl. 11.5 is now available containing the new Ph. Eur. Cannabis Flower monograph and the new Ph. Eur. monograph Cannabidiol (CBD).
With the publication of the two Ph. Eur. monographs new reagents are needed for quality control purposes (e.g. for the test on identity via Thin Layer Chromatography in the Cannabis Flower monograph). Hence, the description of these Cannabis reagents is also published in the European Pharmacopoeia (Ph. Eur.) Supplement 11.5.
Moreover the Ph. Eur. Cannabis Flower Monograph requires the use of cannabis flower for system suitability HRS (herbal reference standard) and cannabidiol for cannabis CRS (chemical reference substance). These reference standards/substances that are described in the newly adopted Ph. Eur. monograph Cannabis flower are now available.
In addition, the reference standards (Cannabidiol CRS, Cannabidiol for system suitability CRS) required for the new Ph. Eur. monograph Cannabidiol (CBD) can be ordered.
More information is available in the announcement on the EDQM website and on the EDQM reference standards ordering website.
Related GMP News
23.04.2026EMA publishes Draft Guideline on the Declaration of Active Substances in Herbal Drugs
23.04.2026Plans to reclassify Hexahydrocannabinol
02.04.2026What are the GMP Requirements for Medical Cannabis?
02.04.2026EFSA sets Cannabidiol (CBD) Safety Limit
02.04.2026What are the GMP Requirements for Herbal Medicinal Products?
03.03.2026Can Steam Treatment be used to Decontaminate Cannabis?


